Abnormal expression of INCENP has not been reported in any cancer experiments. However, our study showed that INCENP was not differentially expressed in overall-stage STAD but was significantly upregulated in progressive-stage STAD, indicating that INCENP might be a novel biomarker of progressive-stage STAD. The gene discussed is INCENP; the disease is cancer.